Congenital afibrinogenemia

American Journal of Hematology

Volumn 46, Issue 4, 1994, Pages 343-347

  Al‐Mondhiry, Hamid ^a   Ehmann, W Christopher ^a  

^a PENN STATE COLLEGE OF MEDICINE   (United States)

Author keywords

afibrinogenemia; congenital; fibrinogen

Indexed keywords

FIBRINOGEN;

AFIBRINOGENEMIA; AUTOSOMAL RECESSIVE DISORDER; CRYOPRECIPITATE; DRUG THERAPY; HUMAN; PRIORITY JOURNAL; REVIEW;

AFIBRINOGENEMIA; DIAGNOSIS, DIFFERENTIAL; FIBRINOGEN; HUMAN; INCIDENCE;

EID: 0027981489     PISSN: 03618609     EISSN: 10968652     Source Type: Journal    
DOI: 10.1002/ajh.2830460416     Document Type: Review

References (56)

1. Fibrinogen γ chain locus is on chromosome 4 in man
2. Organization and evolution of the human fibrinogen locus on chromosomefour
3. Nucleotide sequences of the three genes coding for human fibrinogen
4. Adhesive interactions of blood cells and the vessel wall
5. Fibrinogen as a risk factor for stroke and myocardial infarction
6. A major coronary risk factor
7. Fibrinogen and risk of cardiovascular disease: The Framingham Study
8. Update on fibrinogen as a major cardiovascular risk factor: The Framingham Study
9. Uber Faserstoffmangel im Blut bci einem Falle von Haemophilie
10. Congenital abnormalities of fibrinogen
11. Fibrinogen abnormalities
12. Genetic disorders of blood coagulation: Clinical manifestation and management
13. Congenital afibrinogenemia in 10 offspring of uncle‐niece marriages
14. Disorders of plasma fibrinogen synthesis
15. Multiple pulmonary emboli in a patient with afibrinogenaemia
16. Analysis of fibrinogen genes in patients with congenital afibrinogenemia
17. Fatal pulmonary embolus in congenital fibrinopenia
18. Congenital afibrinogenaemia and recurrent early abortion: A case report
19. Inherited bleeding syndromes in Iraq
20. First report of a case of congenital afibrinogenemia with successful delivery
21. Hereditary coagulation disorders
22. Congenital abnormalities of fibrinogen
23. Congenital afibrinogenemia and splenic rupture
24. Afibrinogenemia with cerebral hematoma
25. A case of congenital afibrinogenemia with abortion, intracranial hemorrhage and peritonitis
26. Congenital afibrinogenaemia and successful pregnancy
27. Pregnancy in congenital afibrinogenaemia: Report of a successful case and review of the literature
28. Coexistence of congenital afibrinogenemia and protein C deficiency in a patient
29. Diagnostische und therapeutische Probleme bei congenitaler Afibrinogenamie
30. Influence of fibrinogen on the aggregation of washed human platelets induced by adenosine diphosphate, thrombin, collagen and adrenalin
31. A case of congenital afibrinogenemia and review of reported cases in Japan
32. Fibrinogen and platelets in the primary arrest of bleeding: Studies in two patients with congenital afibrinogenemia
33. Fibrinogen and adenosine diphosphate‐induced aggregation of platelets
34. Platelet function in congenital afibrinogenemia
35. Plasma protein requirement for human platelet aggregation
36. Immunological studies of proteins associated with subcellular fractions of thrombasthenic and afibrinogenaemic platelets
37. Fibrinogen‐independent aggregation and deaggregation of human platelets: Studies in two afibrinogenemic patients
38. Delayed‐type hypersensitivity skin reactions in congenital afibrinogenemia lack fibrin deposition and induration
39. Fibrinogen depletion with sodium valproate
40. Neonatal afibrinogenaemia due to sodium valproate
41. Hypofibrinogenemia and coagulation factor deficiencies with L‐aspariginase treatment
42. Metabolism and distribution of fibrinogen II. Fibrinogen turnover in polycythemia, thrombocytosis, haemophilia A, congenital afibrinogenemia and during streptokinase therapy
43. The molecular biology of fibrinogen
44. Fibrinogen precursors: Order of assembly of fibrinogen chains
45. Cryoprecipitate as a reliable source of fibrinogen replacement
46. Management of the hereditary coagulation disorders
47. Some therapeutic agents influencing hemostasis
48. Preparation and clinical use of plasma and plasma fractions
49. Use of a new solvent‐detergent/heat‐treated fibrinogen concentrate in a child with afibrinogenemia
50. Prophylactic cryoprecipitate in congenital afibrinogenemia
51. Von Willebrand factor interaction with the Glycoprotein IIb/IIIa complex: Its role in platelet function as demonstrated in patients with congenital afibrinogenemia
52. Effect of DDAVP on primary hemostasis with congenital afibrinogenemia
53. Failure of DDA VP to shorten the prolonged bleeding time of two patients with congenital afibrinogenemia
54. Kongenitale afibrinogenamie: Mitteilung eines Falles mit multiplen Knochenzysten und Bildung eines spezifischen Antikörpers (antifibrinogen) nach Blutttransfusionen
55. Precipitating antifibrinogen antibody appearing after fibrinogen infusions in a patient with congenital afibrinogenemia